ArticleJournal of clinical and translational hepatology2025

FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.